FDA approves Hikma’s generic version of Novo’s diabetes drug Victoza By Reuters Published Dec. 23, 2024, 8:59 p.m. ET The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another…
Continue reading...